Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CASE STUDIES
May 18, 2023
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
Blog Post
November 17, 2022
How does public health surveillance work, and how can it be done better? Amanda Glassman tackles these questions with Dr. Oliver Morgan of the WHO and Dr. Theo Vos of the Institute for Health Metrics and Evaluation. Together, they examine the successes and limitations of public health surveillance d...
Blog Post
September 22, 2022
The UK is being asked for £1.8 billion, making this one of the biggest decisions facing James Cleverly, the new Secretary of State, within his first two weeks of the job. We will review what is known about the FCDO’s likely commitment, and recommend four key questions that the new Secretary of State...
Blog Post
September 15, 2022
Countries in Latin America were hit especially hard by the COVID-19 pandemic. On this episode of Pandemic Proof, Amanda Glassman welcomes Dr. Jarbas Barbosa da Silva Jr., candidate for Director of the Pan American Health Organization (PAHO), to the podcast to discuss impacts and lessons learned. Tog...
Blog Post
July 15, 2022
In this blog, we look at how economic conditions are likely to further compromise public health financing in the region, how smaller health budgets will be coupled with increasing demands, and what policymakers can do to minimize the negative impact on the health of their populations.
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
Blog Post
August 02, 2021
Access to safe, effective, and affordable essential medicines is an integral global health goal, and all the more important during a public health emergency like COVID-19. Supply chain inefficiencies, procurement capacity constraints, and financial difficulties impede access to affordable, quality m...